Abstract
Historically, pyogenic vertebral osteomyelitis was disease with high morbidity and mortality rate. In recent years, with advance of new diagnostic techniques, antimicrobial chemotherapy, and improvement in surgical techniques, the prognosis has improved dramatically. However, as a recent tendency, the number of patients tends to increase by aging of the patient, increase of immuno-compromised host and resistant bacteria. There is a case the spine infection with immuno-compromised host sometimes accompanies sepsis and to die. Therefore, the management of this disease has still many pitfalls and problems. An early diagnosis is necessary, and identification of causative organism and appropriate antimicrobial chemotherapy are basics of treatment. But when indicated, we should cooperate with a spinal surgeon closely, and choose surgical intervention.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
